"Hope Clinical Research is a dedicated research site coupled with multi-specialty and family practice doctors that conducts Phase I-IV research studies. Our research team has been conducting clinical trials for over 5+ years in urban Los Angeles, California."

During the past decade, Hope Clinical Research conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 30 clinical trials were completed, i.e. on average, 44.8% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 30 clinical trials were completed. i.e. 69.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hope Clinical Research" #1 sponsor was "Allergan" with 9 trials, followed by "Pfizer" with 9 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored, "Flexion Therapeutics, Inc." with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hope Clinical Research" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "Affibody" with 1 trials as a collaborator, "Clinical Research Management, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Hope Clinical Research" are "Atopic Dermatitis" (4 trials), "COVID-19" (4 trials), "Diabetes Mellitus" (4 trials), "Gastroparesis" (4 trials) and "Osteoarthritis, Hip" (3 trials). Many other conditions were trialed in "Hope Clinical Research" in a lesser frequency.

Most popular intervention types in "Hope Clinical Research" are "Drug" (54 trials), "Biological" (10 trials), "Other" (4 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Placebo oral tablet" (3 trials), "Relamorelin" (3 trials), "APT-1011" (2 trials) and "CTP-543" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hope Clinical Research" are 63 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hope Clinical Research". undefined are not yet recruiting, 14 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 30 completed trials in Hope Clinical Research, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Hope Clinical Research, 0 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".